396 related articles for article (PubMed ID: 25351198)
1. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.
Frey N; Linke A; Süselbeck T; Müller-Ehmsen J; Vermeersch P; Schoors D; Rosenberg M; Bea F; Tuvia S; Leor J
Circ Cardiovasc Interv; 2014 Dec; 7(6):806-12. PubMed ID: 25351198
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.
Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; Liu J; Gibson CM; Harrison RW; Joseph DS; Heyrman R; Krucoff MW
Am Heart J; 2015 Nov; 170(5):929-37. PubMed ID: 26542501
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
Leor J; Tuvia S; Guetta V; Manczur F; Castel D; Willenz U; Petneházy O; Landa N; Feinberg MS; Konen E; Goitein O; Tsur-Gang O; Shaul M; Klapper L; Cohen S
J Am Coll Cardiol; 2009 Sep; 54(11):1014-23. PubMed ID: 19729119
[TBL] [Abstract][Full Text] [Related]
4. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.
Landa N; Miller L; Feinberg MS; Holbova R; Shachar M; Freeman I; Cohen S; Leor J
Circulation; 2008 Mar; 117(11):1388-96. PubMed ID: 18316487
[TBL] [Abstract][Full Text] [Related]
5. Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; White JA; Liu J; Levy H; Guetta V; Gibson CM; Tanguay JF; Vermeersch P; Roncalli J; Kasprzak JD; Henry TD; Frey N; Kracoff O; Traverse JH; Chew DP; Lopez-Sendon J; Heyrman R; Krucoff MW
J Am Coll Cardiol; 2016 Aug; 68(7):715-23. PubMed ID: 27515331
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
8. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
[TBL] [Abstract][Full Text] [Related]
10. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F
Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209
[TBL] [Abstract][Full Text] [Related]
11. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
[TBL] [Abstract][Full Text] [Related]
12. Predictors of myocardial contractile recovery after coronary revascularization in patients with prior myocardial infarction.
Abdel-Salam Z; Nammas W
Cardiovasc Revasc Med; 2010; 11(1):2-7. PubMed ID: 20129355
[TBL] [Abstract][Full Text] [Related]
13. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.
Achilli F; Malafronte C; Cesana F; Maggiolini S; Mauro C; De Ferrari GM; Lenatti L; Tespili M; Pasqualini P; Gentile F; Capogrossi MC; Maggioni A; Maseri A; Pontone G; Colombo GI; Pompilio G;
Am Heart J; 2015 Oct; 170(4):652-658.e7. PubMed ID: 26386788
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM
Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892
[TBL] [Abstract][Full Text] [Related]
18. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
[TBL] [Abstract][Full Text] [Related]
19. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds.
Balakrishnan B; Jayakrishnan A
Biomaterials; 2005 Jun; 26(18):3941-51. PubMed ID: 15626441
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of adverse cardiac events in patients with acute anterior wall myocardial infarction treated with PCI].
Wita K; Filipecki A; Szczogiel J; Drzewiecka-Gerber A; Rybicka A; Krauze J; Wróbel W; Szydło K; Urbańczyk D; Turski M; Tabor Z; Kwaśniewski W; Mróz I; Trusz-Gluza M
Pol Arch Med Wewn; 2006 Jul; 116(1):648-57. PubMed ID: 17340971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
